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  Use the PICO framework to formulate a specific clinical 
question.
  Formulate a search strategy.
  Prospectively register the review protocol.
  Execute the literature search.
  Apply eligibility criteria to exclude irrelevant studies.
  Extract data and appraise each study for risk of bias and 
external validity.
  Provide a narrative review.
  If appropriate data are available, perform a meta-analysis.
  Report the review findings in the context of the risk of bias 
assessment, any sensitivity analyses and the analysis of risk 
of publication bias.
  Useful resources include the Cochrane Handbook, PROS-
PERO, GRADE and PRISMA.
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Introduction
In the 10 years after the 2002 New England Journal of Med-
icine (NEJM) publication of a trial that demonstrated no 
benefit of arthroscopic versus sham surgery for knee oste-
oarthritis,1 the procedure paradoxically gained popularity 
and became the most commonly performed orthopaedic 
surgery in all countries collecting such data. Subsequent 
trials that confirmed the findings of the NEJM publication 
were conducted, published and largely ignored.2 It took a 
review of the totality of the evidence, published in the BMJ 
in 2015,3 to show beyond doubt that there was no justifi-
cation for such practice. It is alarming to consider the 
quantity of medical resources wasted during this period, 
how they could have been better allocated and the 
number of inadvertent complications that occurred as a 
result of this practice.
Evidence synthesis is the bringing together of all the 
available evidence that meets a predetermined quality 
assessment and combining, pooling or describing that 
data with methods appropriate to the type of evidence and 
data available. Non-systematic reviews are prone to influ-
ence by the unconscious or conscious bias of the authors. 
Systematic reviews offer a thorough appraisal and sum-
mary of the evidence and thereby inform clinical practice. 
They are increasingly seen as providing the most reliable 
conclusions about treatments. Another important role of 
systematic reviews is to highlight where no reliable evi-
dence exists (for example only level 3 or 4 studies), thereby 
directing future research. In this article, we discuss the ori-
gins of systematic review and summarize the methodol-
ogy for performing such work and the meta-analysis which 
may follow if appropriate data are available.
Pioneering work
The first attempt at a systematic review was performed by 
James Lind in 1753. In an era when more than half of a 
ship’s crew could perish from scurvy, Lind studied this dis-
ease in great detail and was aware of numerous biases 
existing within the literature. He also realized the impor-
tance of a meticulous unbiased review of the ‘wealth’ of 
available literature. While serving as the ship’s surgeon on 
board HMS Salisbury in 1747, he trialled different dietary 
supplements for sailors suffering with scurvy, meticu-
lously controlling all other aspects of the sailors’ diets.4 As 
a result, he rapidly identified a cure in lemons and, subse-
quently, limes. He applied this meticulous ideology to his 
treatise on scurvy:
‘…it is no easy matter to root out prejudices,… It became 
requisite to exhibit a full and impartial view of what had 
hitherto been published on the scurvy… Indeed before the 
subjects could be set in a clear and proper light, it was 
necessary to remove a great deal of rubbish.’4
How to prepare and manage a systematic review and 
meta-analysis of clinical studies
James R. Berstock1
Michael R. Whitehouse2,3
4.1800EOR0010.1302/2058-5241.4.180049
research-article2019
 General Orthopaedics  
214
What is a systematic review?
Chalmers and Altman define a systematic review as a 
review that has been prepared using a systematic 
approach to minimizing biases and random errors where 
the objectives are made clear and the process explicitly 
documented in the materials and methods section of the 
review.5 A systematic review may or may not include a 
meta-analysis: a statistical analysis of the amalgamated 
results from independent studies, which generally aims to 
produce a single estimate of a treatment effect. For a sim-
ple clinical meta-analysis, studies must investigate the 
same intervention and comparator groups and measure 
the same outcome data or that data be obtainable from 
the authors.
The key differences between a review article and a sys-
tematic review are the explicit steps necessary to demon-
strate the elimination of bias. A systematic review must be 
carried out with the same scientific rigour that is associ-
ated with a randomized controlled trial (RCT). There is a 
need for a very careful consideration of the numerous 
potential biases that exist within the literature, the direc-
tion and magnitude of their effect, and the implications 
this may have for clinical practice. Ensuring a review is 
truly unbiased is no small undertaking. For any reader 
considering undertaking a review, the comprehensive 
Cochrane Handbook for Systematic Reviews of Interventions 
is available as a free online resource. This article serves as 
a brief summary.
What is involved in a systematic review?
The systematic review process can be broken down into a 
few steps. A similar guide by Harris et al exists.6
Formulate the question
Initially, this is an iterative process, requiring the reviewer 
to consider the question to be addressed and the relevant 
existing literature. The purpose of this is to give the 
reviewer an understanding of the type of studies that 
already exist in the literature and enable one to think 
about what an ideal study might look like in terms of 
patients, intervention, comparator and outcomes (PICO).5 
Think about the features of methodological quality which 
could form the basis of inclusion or exclusion criteria. A 
well formulated concise question with a clear plan from 
the beginning will save a lot of time and effort later in the 
process. It is also worth checking to see if a recent system-
atic review that matches your question has been pub-
lished or registered.
Develop a protocol
Once a clear review question has been formulated, 
thought must be given to defining specific inclusion and 
exclusion criteria for potential studies within a review. 
Parameters such as the age limits of participants, whether 
some aetiologies should be excluded and which specific 
interventions and reported outcomes are of interest 
should be specified in the protocol. Reviewers also need 
to consider the level of evidence to be included. Reviews 
are usually confined to the highest level of evidence avail-
able. Ideally multiple RCTs will exist; however, for some 
clinical questions this level of evidence is unavailable and 
therefore a review of non-randomized studies may be 
helpful. It is generally advisable to include all relevant 
studies, but there may be occasions where clinical practice 
has changed so radically that historic studies are no longer 
relevant and should be excluded. It is generally not accept-
able to exclude studies based on the language of publica-
tion. Having some idea of the quality of evidence available 
is helpful before writing a detailed and explicit protocol. 
The protocol should be published before commencement 
of the review itself. This reduces bias from ‘cherry picking’ 
evidence and largely distinguishes a systematic review 
from a non-systematic literature review. The protocol 
requires the review team to think carefully about exactly 
what question they are trying to answer and what type of 
evidence may bias the overall findings of the review. The 
PROSPERO International Prospective Register of System-
atic Reviews is a quick, free and open-access method of 
publishing a review protocol (https://www.crd.york.ac. 
uk/prospero/). Once registered, a systematic review will 
be assigned a registry number similar to that of a RCT. 
Review protocols may alternatively be published in jour-
nals such as BMJ Open and Systematic Reviews. Once the 
protocol has been agreed upon and published, the search 
for literature may begin.
Literature search
There are several tiers of literature: some is electronically 
searchable via Medline, Embase, Pubmed, Google Scholar 
or the trials registries, while some literature exists in jour-
nals which are not Medicus Indicus listed. In addition, 
conference abstracts and proceedings of major journals 
may not be accessible online (this is known as grey litera-
ture). Some studies occur within theses, which are only 
accessible by visiting university libraries; some evidence 
may never have been submitted for publication but exists 
in an even less inaccessible form. The latter category is 
known as the file drawer problem and is believed to be a 
larger contributor to publication bias than editors or jour-
nals rejecting studies at the review stage. Methods are 
available for identifying and adjusting for this publication 
bias which will be discussed later.
Generally speaking, the greater the efforts to identify all 
the evidence, the more reliable a review is considered. For 
this reason, multiple databases are often used to search 
for studies. Embase and Medline would represent the 
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minimum number of bibliographic databases to search, 
each containing different subsets of the medical literature. 
The number of databases required will depend on the 
nature of the review being conducted and the availability 
of the evidence. Specific search terms exist for each data-
base; help with the construction of search strategies, 
including the use of MESH and specific search modifiers, is 
available online. In addition to hand searching the grey lit-
erature, it is generally accepted that searches should not 
be limited to the English language or just publications 
from recent years without good reason. Good practice 
would suggest that personal communications with experts 
in the field, contacting authors and searching the reference 
lists of included studies and other relevant articles may 
unearth additional evidence for inclusion in a systematic 
review. The searches must be detailed, exhaustive, repeat-
able and documented in order to find all the relevant pub-
lished and unpublished studies and to demonstrate 
reliability. Ultimately, though, a balance must be struck 
between a truly exhaustive search and the practical con-
straints of time, cost and other resources. Judgement must 
therefore be used in setting the appropriate sensitivity and 
specificity for a particular search strategy. The review team 
usually collectively agree on the search strategy before eli-
gibility criteria are applied by two independent members 
of the review team. It is becoming reasonable to assume 
that the highest quality clinical trials are available in main-
stream journals which are all easily identifiable via searches 
of one or two electronic databases. Identifying lower qual-
ity evidence may therefore require more extensive searches.
Apply eligibility criteria
Once the electronic searches have been executed, each 
potential study must be assessed for eligibility of inclusion 
against predetermined criteria. This process must be 
checked by two reviewers acting independently. Formal 
rules, laid down in the protocol, are required to prevent 
selective inclusion of studies that support the reviewers’ 
opinions. Disagreements may be settled through arbitra-
tion from a third reviewer or, in the case of disagreement 
when there is not a third reviewer, to include the paper. 
Many studies can be eliminated by briefly reading the 
abstract alone, but others require review of the full manu-
script or require translation of a foreign language manu-
script before eligibility criteria can be applied. Bibliographic 
managers such as EndNote may be helpful for logging 
eligibility decisions and managing this part of the process. 
The numbers of studies at each stage of the search are 
usually summarized by means of a flow diagram (Fig. 1).
Extract data
To reduce bias, data extraction should also be performed 
by two reviewers independently, usually recorded onto a 
standardized proforma for each study included in the 
review. The type of data to be extracted should be speci-
fied in the protocol. This usually includes when and where 
the study was performed, a summary of the methodology 
and primary outcome measure used, the number of par-
ticipants in each intervention group, summary demo-
graphic data for each group regarding age, gender, 
aetiology, outcome measures, complications and length 
of follow-up.
Assess risk of bias
Bias can be introduced by flawed study designs, inappro-
priate patient selection and biased treatment group allo-
cation, known and unknown confounders, at the data 
collection or analysis stages, and, of course, publication 
bias can skew the available literature.
The Cochrane risk of bias tool provides a standardized 
guide for considering where bias may creep into a RCT.6 
The categories are very general and include: sequence 
generation; allocation concealment; masking of partici-
pants and assessors; incomplete outcome data; and selec-
tive reporting. Randomization is a key part of reducing 
selection bias and is not always adequate, e.g. quasi-rand-
omization by alternating day of the week on which an 
intervention is performed. In the case of non-randomized 
studies, alternative tools such as the Newcastle-Ottawa 
Scale are available.
The risk of bias assessment described above focuses on 
internal validity, i.e. the extent to which overall systematic 
error (bias) is minimized in a clinical study. Consideration 
now needs to be given to external validity, which is the 
extent to which the results of a trial offers an accurate 
basis for applicability to real-life clinical circumstances. For 
example, a theoretical trial of the lateral versus posterior 
approach for hip replacement may under-report any dif-
ference in dislocation rate if patients in both arms of the 
trial receive constrained acetabular components. In the 
same example, limiting follow-up to include only the first 
post-operative days of a strictly enforced period of hip 
precautions in the inpatient stay may have a similar effect. 
In both examples, the test was fair but lacked generaliza-
bility, known as external validity. The circumstances and 
delivery of interventions may therefore impact the exter-
nal validity of an otherwise well-conducted study and 
need careful assessment.
The assessment of bias is crucial to systematic reviews. 
Authors must describe where potential bias occurred in an 
individual study and then make a judgement call to deter-
mine whether this would cause a low, high or an unclear 
risk of bias. Finally, the magnitude and direction each bias 
may have on the results being reported in a study are also 
important to consider. For example, inadequate blinding 
of patients has more of a deleterious effect on subjective 
outcomes such as satisfaction or functional score than it 
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does for objective outcomes such as mortality. The risk of 
bias is usually summarized in a table (Table 1).
Provide a descriptive synthesis
A descriptive synthesis of the studies included in the sys-
tematic review with a rigorous attempt to eliminate the 
effect of biases is challenging but forms the write-up stage 
of the systematic review. GRADE guidelines are useful for 
considering the strength of any recommendations or con-
clusions one may be able to draw.7 The PRISMA checklist 
is also useful for demonstrating that the systematic review 
has followed agreed standards in reporting systematic 
reviews.8 It is worth reviewing the PRISMA checklist before 
commencing the write-up as it provides a logical, com-
prehensive and reproducible structure to the report.
Meta-analysis
So far, this article has discussed how to take an explicitly 
unbiased approach to gathering all the information on a 
topic, critically appraising and synthesizing it to answer a 
clinical question. When such studies contain data, it is pos-
sible to pool results together giving a weighting according 
to our confidence in them. This is a statistical process 
known as meta-analysis. Freely downloadable software 
such as Review Manager can be used to perform meta-anal-
ysis and to create forest plots, such as that shown in Fig. 2.
26 full-text articles excluded:
Retrospective (n = 6)
Review article (n = 3)
Cadaveric study (n = 3)
Comparative cohort (n = 6)
No comparison group (n = 6)
Duplicate records (n = 2)
941 records identified
through database searching
(Cochrane CENTRAL, MEDLINE, EMBASE,
AMED, complimentary medicine and CAB
abstracts)
613 records
after duplicates
removed
Screening
4 records identified through other sources
(Wright 2004, Sharma 2006, Shitama 2009,
Bennett 2007)
Eligibility
Included
Identification
613 records
screened
42 full-text
articles assessed
for eligibility
16 studies
included in
qualitative
review
16 studies included in
meta-analysis.
571 records
irrelevant
Fig. 1 Example study flow diagram.
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Interpreting a forest plot
A forest plot is a visual representation of the results of a 
meta-analysis (Fig. 2). Trials are usually ordered by weight-
ing or year of publication. Each square corresponds to the 
risk or odds ratio, the size of the square to the sample size 
and the horizontal lines correspond to the 95% confidence 
intervals (CI). The centre of the diamond represents the 
pooled relative risk or odds ratio with its 95% CI denoted 
by its width.
The headline results of a meta-analysis are usually 
denoted by a summary mean difference or risk ratio, a 
95% CI and a test of overall statistical significance 
expressed as a p-value. These three values indicate the 
magnitude of the treatment effect, the spread and the sta-
tistical significance of the effect. These data are most use-
ful but should not be considered individually. For example, 
pooling of large amounts of data may produce very small 
p-values, suggesting a strongly statistically significant 
result; however, the actual size of the effect may be small 
and clinically of little relevance. Confidence intervals may 
also indicate that the true treatment effect may be harm-
ful, despite the mean pooled effect indicating benefit. This 
would usually indicate that more studies are required in 
order for a definitive conclusion to be drawn.
Statistical assumptions
Broadly speaking, there are two different assumptions on 
which meta-analysis can be performed. These are the fixed 
and random-effects models. A fixed effects meta-analysis 
assumes that all studies are measuring the same underly-
ing treatment effect and, if it was not for random (sam-
pling) error, all results would be identical. In this model, 
larger studies tend to get a larger weighting. This is usu-
ally an advantageous assumption when there is low het-
erogeneity between studies.
The random-effects model assumes that the true treat-
ment effect actually varies between studies to form a nor-
mal distribution of effect sizes. When significant inter-study 
heterogeneity exists, this is usually the preferable model. 
Table 1. Example of a Cochrane risk of bias table
Author (year) Khan (2012) Goosen (2011) Fink (2010) Shitama (2009)
Random sequence generation
Allocation concealment
Blinding of participants
Blinding of outcome assessment
Incomplete outcome data (attrition bias)
Selective reporting
Grading system:  high risk of bias;  unclear risk of bias;  low risk of bias
-4 -2 0
Favours SV Favours MP
2 4
Study or Subgroup
Weinhardt 2004
Pan 2010
Bourke 2012
Jung 2009
Roysam 2001
Hafez 2002
Boerger 2005
Jain 2013
Total (95% CI)
Heterogeneity: Chi2 = 45.69, df = 7 (P < 0.00001); I2 = 85%
Test for overall effect: Z = 10.36 (P < 0.00001)
Mean
8.3
1.9
1.9
0.5
3.2
3.4
3.2
1.64
Mean
12
4.2
2.8
2.2
5.8
4.5
4.1
2.08
SD
2.8
2.75
1.6
0.8
1.4
0.924
1.3
1.4
SD
3.1
2.75
1.9
1.4
1.7
1.57
1.5
1.7
Total
26
35
36
21
46
40
60
100
364
Total
26
33
37
19
43
47
60
100
365
Weight
2.0%
3.0%
7.8%
9.9%
12.0%
17.9%
20.1%
27.3%
100.0%
IV, Fixed, 95% CI
-3.70 [-5.31, -2.09]
-2.30 [-3.61, -0.99]
-0.90 [-1.70, -0.10]
-1.70 [-2.42, -0.98]
-2.60 [-3.25, -1.95]
-1.10 [-1.63, -0.57]
-0.90 [-1.40, -0.40]
-0.44 [-0.87, -0.01]
-1.19 [-1.42, -0.97]
Mean Difference
IV, Fixed, 95% CI
Mean DifferenceMedial parapatellarSubvastus
Fig. 2 Forest plot of return of active straight leg raise following either subvastus or medial parapatellar approach to total knee 
replacement. Pooled data from eight RCTs show that SLR returns 1.19 days earlier with use of the subvastus approach, (95% CI 0.97 
to 1.42, p < 0.00001). Data from: Berstock JR, Murray JR, Whitehouse MR, Blom AW, Beswick AD. Medial subvastus versus the medial 
parapatellar approach for total knee replacement: A systematic review and meta-analysis of randomized controlled trials. EFORT Open 
Rev 2018;3:78–84.
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However, it has the effect of increasing the weighting of 
smaller studies and accordingly decreases the weighting 
of larger studies. This may not be desirable if the smaller 
studies are thought to be methodologically less reliable.
Publication bias
Funnel plots can be used to help detect publication bias 
(Fig. 3). Publication bias arises from the way researchers 
and journal editors have a tendency to handle positive and 
negative study findings differently. A funnel plot is essen-
tially a graph of the inverse of the standard error of a study 
on the y-axis and individual study effect size on the x-axis. If 
enough studies exist, a triangle or inverted funnel will 
emerge if there is no evidence of publication bias. The large 
studies with small standard errors accumulate near the top 
of the chart, close to the pooled effect size, while the small 
studies are usually subject to larger sampling error and dis-
play a wider spread of results around the pooled effect size. 
When part of the triangle is missing, there is said to be 
asymmetry, which may indicate publication bias.
Usually, in the presence of publication bias, studies in 
the low left-hand part of the funnel are absent. These are 
small, negative studies. The ‘trim and fill’ method may be 
used when there is asymmetry in the funnel plot. This cor-
rects the results of a meta-analysis in the face of a publica-
tion bias. This method also estimates how many studies 
are missing as a direct result of publication bias.
Sensitivity analysis
Following meta-analysis, various assumptions can be 
tested to identify the robustness of the pooled effect size. 
These are known as sensitivity analyses and should be 
defined a priori in the study protocol rather than on a post 
hoc basis. Usually heterogeneity is examined. Heterogene-
ity is the difference between individual study findings that 
is not due to chance. Clinical heterogeneity is often pre-
sent, e.g. small differences in the delivery of the interven-
tion and differing patient demographics or response to 
treatment. Clinical judgement must be used to postulate 
the cause of heterogeneity.
Quantifying heterogeneity may be useful. The I2 test 
represents the difference between observations in studies 
that would not be expected by statistical chance alone. 
Conventionally, I2 < 25% signifies low heterogeneity, 
whereas I2 > 75% indicates a high level of heterogeneity.
The potential causes of such heterogeneity need careful 
consideration. Heterogeneity may be due to patient diver-
sity, different treatment effects or study bias, and can be 
explored using subgroup analysis, meta-regression or a 
funnel plot. For example, cultural, temporal and geo-
graphical differences in social care and expectations of 
length of stay following arthroplasty surgery may contrib-
ute to a wide variation in worldwide studies reporting this 
Study, Year
Baser, 2011
Belmont, 2014
Blum, 2013
Cram, 2012
Duchman, 2014
Easterlin, 2013
Haughtom, 2014
Hart, 2014
Huddleston, 2009
Hunt, 2014
Husted, 2006
Jorgensen, 2015
Lie, 2010
Lee, 2016
Maempel, 2015
Memtsoudis, 2014
Miric, 2014
Parry, 2011
POMR, 2015
Pugely, 2013
Seah, 2007
Singh, 2012
Singh, 2011
Stundner, 2014
SooHoo, 2006
Smith, 2015
Suleiman, 2012
0 0.2 0.4
30-day mortality %
0.6 0.8
Fig. 4 Simplified forest plot of 30-day mortality following total 
knee replacement. Pooled data from 1.8 million total knee 
replacements, 30-day mortality 0.19% (95% CI 0.15 to 0.23). 
0
2
4
6
8
10
-20 -10 0 10 20
MD
SE(MD)
Fig. 3 A theoretical funnel plot demonstrating an absence 
of small studies reporting a negative effect, suggestive of a 
publication bias. The central vertical line shows the pooled 
effect size and each circle represents a study. Larger studies with 
a smaller standard error are located at the apex of the triangle. 
Smaller studies are expected to distribute on both sides of the 
overall effect size line, but in this example do not.
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as an outcome measure. Subgroup analyses of studies 
grouped by geographic region or decade of study might 
produce more homogenous results, therefore explaining 
the observed heterogeneity supporting the initial hypoth-
esis. While subgroup analyses are good for categorical 
covariates, meta-regression is often used to explore rela-
tionships between continuous covariates. Meta-regression 
could for example be used to explore a temporal trend 
towards shorter lengths of stay that could not be investi-
gated in any of the original studies.
Meta-regression
Meta-regression is the meta-analysists equivalent of simple 
or multiple regression in cohort studies. Additional co-var-
iates may be studied for their effect within a meta-analysis. 
For example, studies reporting 30-day mortality following 
total knee replacement can be displayed in a forest plot 
(Fig. 4). Meta-regression can be used to determine the 
effect of a co-variate, such as median year of data collec-
tion on the overall meta-analysis (Fig. 5). Study weighting 
is retained in meta-regression, whereas in simple regres-
sion there is no weighting.
Individual patient data meta-analysis
Individual patient (or participant) meta-analysis is a subtype 
of the meta-analysis technique. Rather than being reliant on 
the summary aggregate data typically reported in publica-
tions describing RCTs, standardized patient level trial data 
are sought from authors to create a combined common 
dataset across multiple trials. This allows for re-analysis of 
the data to provide an overall estimate of the treatment 
effect of an intervention. This method is very resource-inten-
sive and difficult to do but can offer novel and definitive 
answers that may be missed in the analysis of summary data 
alone. For this reason, the Cochrane Methods Group recog-
nizes this as the ‘gold standard’ of systematic review.9
Network meta-analysis
Network meta-analysis is a method for establishing the 
treatment effect of interventions not directly compared 
when there are appropriate randomized studies available 
with a common comparator. This method is typically 
more representative of clinical decision-making regarding 
the treatment of patients where there may be multiple 
treatment options. The common comparators are defined 
and networks formed to establish where effects can be 
assessed between different interventions (Fig. 6). Where 
there are two RCTs, the first comparing intervention A and 
intervention B and the second comparing intervention A 
and intervention C with common outcomes reported, 
combining the data from these studies allows clinically 
relevant estimates to be made of the differences between 
interventions B and C. These networks are then built up in 
increasing layers of complexity.
1994
30-day
mortality
Meta-regression of 30-day mortality following knee replacement
1996 1998 2000 2002 2004 2006
Median Year of Study
2008 2010 2012 2014 2016
Fig. 5 Meta-regression of data presented in Fig. 4. Each individual study is represented by a circle, the size of which correlates to 
the weighting of each study. The straight line shows that mortality is seen to decrease with time, with the lines above and below 
representing 95% CIs, which get tighter where more data exist. For this meta-regression R2 = 70%, suggesting that 70% of the 
variation between studies is explained by the year of data collection. Data with permission from: Berstock JR, Beswick AD, López-
López JA, Whitehouse MR, Blom AW. Mortality after total knee arthroplasty: a systematic review of incidence, temporal trends, and 
risk factors. J Bone Joint Surg Am 2018;100:1064–1070.
A
A
B B B D
C A C A C
Fig. 6 Schematic of comparisons possible via network meta-
analysis.
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Conclusions
In a world where medical knowledge is being produced 
at a bewildering rate, the aggregation and rigorous 
appraisal of the totality of available evidence will become 
increasingly important if such information is to be made 
usefully available to clinicians. Evidence synthesis needs 
to be performed in order to gather knowledge, inform 
policy, process and practice, establish the need or the 
lack of need for research in an area and to generate 
hypotheses. The role of systematic review will therefore 
be increasingly important to the future conduct of evi-
dence-based medicine. It is also increasingly unlikely that 
researchers will achieve funding of a study without an 
adequate and robust systematic review of the topic to 
inform the need for research in the area and some jour-
nals require a brief systematic review to accompany all 
submissions. This article serves as a summary of the steps 
required to perform a systematic review. We would 
encourage potential reviewers to refer to the online 
Cochrane Handbook for Systematic Reviews of Interven-
tions for a more detailed description.
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